TriSalus Life Sciences, Inc. TLSI Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s financing cash flow?
- TriSalus Life Sciences, Inc. (TLSI) reported financing cash flow of $42.39M in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s financing cash flow changed year-over-year?
- TriSalus Life Sciences, Inc.'s financing cash flow increased by 337.5% year-over-year, from $9.69M to $42.39M.
- What is the long-term trend for TriSalus Life Sciences, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s financing cash flow has grown at a 174.2% compound annual growth rate (CAGR), from $544K to $30.76M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.